Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2008 Results
Date:10/30/2008

NAL HIGHLIGHTS

On September 10, 2008, Vanda met with the U.S. Food and Drug Administration (FDA) to discuss the not-approvable action letter that the FDA issued to Vanda on July 25, 2008 regarding iloperidone. The FDA asked Vanda to provide a complete response to the not-approvable letter highlighting arguments made during the meeting. Vanda expects to submit the complete response within the next few weeks. The timing or outcome of any FDA review of the response is uncertain at this time.

Vanda has suspended all commercial and development activities pending further review. Vanda has also reduced its cash burn and is reviewing a number of options to further reduce expenses and cash burn.

FINANCIAL DETAILS

Operating Expenses. Third quarter 2008 R&D expenses, primarily consisting of salaries and related costs of R&D personnel, stock-based compensation, and the costs of consultants, materials and supplies associated with clinical trials and research initiatives, totaled $3.8 million, compared to $5.5 million in the second quarter of 2008 and $13.9 million in the third quarter of 2007. The decrease in R&D expenses in the third quarter of 2008 relative to the second quarter of 2008 is primarily attributable to lower costs in the Phase III tasimelteon chronic primary insomnia clinical trial for which Vanda reported top-line results in June of 2008. The decrease in R&D expenses in the third quarter of 2008 relative to the third quarter of 2007 is primarily attributable to lower clinical trial costs in the third quarter of 2008 compared to the costs from trials conducted in the third quarter of 2007 and the $5.0 million milestone charge recorded in the third quarter of 2007 resulting from the submission of the NDA for iloperidone.

-- General and administrative (G&A) expenses totaled $7.4 million in the third quarter of 2008, compared to $8.5 million in the second quarter of 2008 and $9.6 million in the third quarter of 2007. The decrease in
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Waterloo, ON (PRWEB) August 01, 2014 ... researchers has led to a better understanding embryonic ... differentiate and reorganize into structurally and functionally distinct ... devastating physical defects. Prof. Todd McDevitt, Melissa ... that biophysical signals interact with biochemical cues to ...
(Date:7/31/2014)... July 31, 2014 Food and ... increasingly searching for food alternatives that offer variety, ... The food ingredient market has numerous players operating ... as Vital Force Technology (VFT). VFT is ... 4,000 energetic patterns, all tested to produce stable, ...
(Date:7/31/2014)... Dallas, Texas (PRWEB) August 01, 2014 ... Global and China Polyurethane Resin Industry” is ... Polyurethane Resin market. The report introduces Polyurethane ... application, and industry chain structure and industry ... analysis, including China’s domestic market as well ...
(Date:7/31/2014)... -- Today BioSpace , the leading life sciences employment and news ... life sciences community in Illinois , Indiana ... Michigan , Minnesota , ... and Wisconsin . BioMidwest is a ... postings on BioSpace originating in this region in 2013. The life sciences ...
Breaking Biology Technology:Study Links Biomechanics and Gene Expression in Stem Cells 2Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 4Midwest Biotech Leaders Featured On BioSpace Map 2
... of voltage, resistance and current with highest accuracy ... prerequisites are extremely pure semiconductor layers where high-mobile ... residual impurities. To be prepared for future developments ... new molecular beam epitaxy system optimized for the ...
... FRANCISCO, Calif., Aug. 29 Anesiva,Inc. (Nasdaq: ANSV ... and chief executive officer, will present at BioCentury,s,Newsmakers in ... September,4, 2008 at 2:00 p.m. ET., To access ... on,to http://www.anesiva.com, go to the Investors page, ...
... Pharmos Corporation,(Nasdaq: PARS ) today announced that ... Rehovot, Israel, and manage those activities currently,based in ... Iselin, New,Jersey., The research programs in Israel ... preclinical development of PRS-639,058 for,neuropathic pain. Additionally the ...
Cached Biology Technology:'Racetrack' for fast electrons in semiconductor structures 2Anesiva to Present at BioCentury Newsmakers Conference on September 4, 2008 2Pharmos Corporation Announces That it Will Cease Operations in Israel 2
(Date:8/1/2014)... a new study, including two Simon Fraser University ... representatives and policymakers must collaborate closely on minimizing ... development. Viorel Popescu and Maureen Ryan, David H. ... department, are among eight international co-authors of the ... and the Environment . , Shale gas development ...
(Date:7/31/2014)... shale rock has increased by more than 700 ... fully understand the industry,s effects on nature and ... Frontiers in Ecology and the Environment . ... scientific examination, a team of eight conservation biologists ... concluded that determining the environmental impact of gas-drilling ...
(Date:7/31/2014)... was found to be a key gene responsible for hearing ... hair cells of the inner ear that contracts and expands ... antique phonograph horn, amplify sound waves to make hearing more ... the advanced online edition of Molecular Biology and Evolution ... also independently evolved to play a critical role in the ...
Breaking Biology News(10 mins):Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3
... Tenn., March 12, 2008 -- Noted green energy entrepreneur ... years Global Venture Challenge, a business competition and venture ... National Laboratory. The focus of this years event ... energy efficiency and power generation sectors. Sridhar, CEO ...
... that could destroy most of the worlds main wheat crops ... than research had suggested, leaving millions to starve. The fungus, ... already be in Pakistan. If so, this is extremely bad ... crop, it is also the gateway to the Asian breadbasket, ...
... Coring in Antarctica), one of the European Science Foundations ... one of this years winners of the Descartes Prize ... to three European teams for outstanding transnational projects in ... 12 March in Brussels. The EPICA project - carried ...
Cached Biology News:Killer fungus spells disaster for wheat 2Killer fungus spells disaster for wheat 3ESF's European ice core project EPICA receives prestigious Descartes Prize 2ESF's European ice core project EPICA receives prestigious Descartes Prize 3
... Convenient, easy-to-use kits for arraying ... detection using common lab equipment. DiscoverLight ... analysis of your protein, cell lysate ... format. The kits include specially designed ...
... facilitate the hybridization of DNA or Protein ... x 75mm glass slides. The proprietary design ... for poor flatness, as is often the ... volume chamber (67uL analytical cavity volume) eliminates ...
MAb to Myoglobin Cardiac...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Biology Products: